Paper7565764
The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
Greco A and 6 others. Mol Cell Biol, 1995. Cited by 178 papers, by iCite.
Cite this record
ConductScience Library. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. Papers, record 7565764. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7565764
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
- PubMed
Topics31
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma | Major topic |
| Chromosome Aberrations | Major topic |
| Chromosomes, Human, Pair 3 | Major topic |
| Oncogenes | Major topic |
| Proteins | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Receptor Protein-Tyrosine Kinases | Major topic |
| Receptors, Nerve Growth Factor | Major topic |
| Thyroid Neoplasms | Major topic |
| 3T3 Cells | |
| Alternative Splicing | |
| Amino Acid Sequence | |
| Animals | |
| Base Sequence | |
| Chromosome Disorders | |
| Cloning, Molecular | |
| Cytoplasm | |
| DNA Primers | |
| DNA, Complementary | |
| Gene Expression Regulation, Neoplastic | |
| Genes | |
| HeLa Cells | |
| Humans | |
| Mice | |
| Molecular Sequence Data | |
| Protein Binding | |
| Protein Structure, Tertiary | |
| RNA, Messenger | |
| Receptor, trkA | |
| Translocation, Genetic | |
| Vesicular Transport Proteins |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2423252 | Mechanism of met oncogene activation. | Cell | 1986 | https://conductscience.org/library/papers/2423252 | PubMed |
| 2 | 2869410 | A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. | Nature | 1986 | https://conductscience.org/library/papers/2869410 | PubMed |
| 3 | 3313277 | An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. | Nucleic Acids Res | 1987 | https://conductscience.org/library/papers/3313277 | PubMed |
| 4 | 3381086 | Amino acid preferences for specific locations at the ends of alpha helices. | Science | 1988 | https://conductscience.org/library/papers/3381086 | PubMed |
| 5 | 2927393 | Molecular and biochemical characterization of the human trk proto-oncogene. | Mol Cell Biol | 1989 | https://conductscience.org/library/papers/2927393 | PubMed |
| 6 | 2531086 | Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours. | EMBO J | 1989 | https://conductscience.org/library/papers/2531086 | PubMed |
| 7 | 2594368 | High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. | Oncogene | 1989 | https://conductscience.org/library/papers/2594368 | PubMed |
| 8 | 2405255 | The Z-DNA motif d(TG)30 promotes reception of information during gene conversion events while stimulating homologous recombination in human cells in culture. | Mol Cell Biol | 1990 | https://conductscience.org/library/papers/2405255 | PubMed |
| 9 | 1969618 | The human minisatellite consensus at breakpoints of oncogene translocations. | Nucleic Acids Res | 1990 | https://conductscience.org/library/papers/1969618 | PubMed |
| 10 | 2189106 | Demonstration by in situ hybridization of ret proto-oncogene mRNA in developing placenta during mid-term of rat gestation. | Oncogene | 1990 | https://conductscience.org/library/papers/2189106 | PubMed |
| 11 | 2216464 | Human TRK proto-oncogene maps to chromosome 1q32-q41. | Oncogene | 1990 | https://conductscience.org/library/papers/2216464 | PubMed |
| 12 | 1701232 | The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. | Oncogene | 1990 | https://conductscience.org/library/papers/1701232 | PubMed |
| 13 | 1849459 | The trk proto-oncogene encodes a receptor for nerve growth factor. | Cell | 1991 | https://conductscience.org/library/papers/1849459 | PubMed |
| 14 | 1850549 | The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. | Science | 1991 | https://conductscience.org/library/papers/1850549 | PubMed |
| 15 | 1829807 | Localization of the TRK proto-oncogene to human chromosome bands 1q23-1q24. | Oncogene | 1991 | https://conductscience.org/library/papers/1829807 | PubMed |
| 16 | 1834975 | The human tropomyosin gene involved in the generation of the TRK oncogene maps to chromosome 1q31. | Oncogene | 1991 | https://conductscience.org/library/papers/1834975 | PubMed |
| 17 | 1751544 | The trk family of tyrosine protein kinase receptors. | Biochim Biophys Acta | 1991 | https://conductscience.org/library/papers/1751544 | PubMed |
| 18 | 1542652 | Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1542652 | PubMed |
| 19 | 1532241 | TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. | Oncogene | 1992 | https://conductscience.org/library/papers/1532241 | PubMed |
| 20 | 1384673 | Cytogenetic and molecular genetic characterization of papillary thyroid carcinomas. | Genes Chromosomes Cancer | 1992 | https://conductscience.org/library/papers/1384673 | PubMed |
Cited by77
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 178 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42309818 | TRK-T3 condensate organization drives growth signaling. | Life Sci Alliance | 2026 | https://conductscience.org/library/papers/42309818 | PubMed |
| 41030651 | Elevated FBXO45 promotes TFG ubiquitination and drives lung metastasis of hepatocellular carcinoma. | JHEP Rep | 2025 | https://conductscience.org/library/papers/41030651 | PubMed |
| 40700600 | ALK-positive adult histiocytosis with a TFG-ALKfusion gene. | Oncologist | 2025 | https://conductscience.org/library/papers/40700600 | PubMed |
| 40047103 | Disease-Associated Factors at the Endoplasmic Reticulum-Golgi Interface. | Traffic | 2025 | https://conductscience.org/library/papers/40047103 | PubMed |
| 38791513 | Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38791513 | PubMed |
| 38681675 | Trk-fused gene plays a critical role in diet-induced adipose tissue expansion and is also involved in thyroid hormone action. | PNAS Nexus | 2024 | https://conductscience.org/library/papers/38681675 | PubMed |
| 37305584 | TFG::ALK fusion in ALK positive large B-cell lymphoma: a case report and review of literature. | Front Oncol | 2023 | https://conductscience.org/library/papers/37305584 | PubMed |
| 37046604 | TrkA Co-Receptors: The Janus Face of TrkA? | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37046604 | PubMed |
| 36408177 | The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy. | Front Oncol | 2022 | https://conductscience.org/library/papers/36408177 | PubMed |
| 36337204 | Changes in TFG gene expression in bovine leucocytes transformed by Theileria annulata. | Front Vet Sci | 2022 | https://conductscience.org/library/papers/36337204 | PubMed |
| 36161950 | TFG regulates secretory and endosomal sorting pathways in neurons to promote their activity and maintenance. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/36161950 | PubMed |
| 35927900 | Research Progress on Small Molecules Inhibitors Targeting TRK Kinases. | Curr Med Chem | 2023 | https://conductscience.org/library/papers/35927900 | PubMed |
| 35172474 | Development of an RNA sequencing panel to detect gene fusions in thyroid cancer. | Genomics Inform | 2021 | https://conductscience.org/library/papers/35172474 | PubMed |
| 35169893 | The oncogenic fusion landscape in pediatric CNS neoplasms. | Acta Neuropathol | 2022 | https://conductscience.org/library/papers/35169893 | PubMed |
| 35121777 | Involvement of neuronal and muscular Trk-fused gene (TFG) defects in the development of neurodegenerative diseases. | Sci Rep | 2022 | https://conductscience.org/library/papers/35121777 | PubMed |
| 34410594 | Sclerosing Polycystic Adenoma: Conclusive Clinical and Molecular Evidence of Its Neoplastic Nature. | Head Neck Pathol | 2022 | https://conductscience.org/library/papers/34410594 | PubMed |
| 33643817 | Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers. | Acta Pharm Sin B | 2021 | https://conductscience.org/library/papers/33643817 | PubMed |
| 33467570 | Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults. | Curr Oncol | 2021 | https://conductscience.org/library/papers/33467570 | PubMed |
| 33411856 | TRK-Fused Gene (TFG), a protein involved in protein secretion pathways, is an essential component of the antiviral innate immune response. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/33411856 | PubMed |
| 33387037 | Kinase gene fusions: roles and therapeutic value in progressive and refractory papillary thyroid cancer. | J Cancer Res Clin Oncol | 2021 | https://conductscience.org/library/papers/33387037 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NTRK1 | 4914 | Swiss-Prot's references | https://conductscience.org/library/genes/4914 | NCBI Gene |
| TFG | 10342 | Swiss-Prot's references | https://conductscience.org/library/genes/10342 | NCBI Gene |
| NGF | 4803 | PubTator's text mining | https://conductscience.org/library/genes/4803 | NCBI Gene |
| RET | 5979 | PubTator's text mining | https://conductscience.org/library/genes/5979 | NCBI Gene |
| TPM3 | 7170 | PubTator's text mining | https://conductscience.org/library/genes/7170 | NCBI Gene |
| TPR | 7175 | PubTator's text mining | https://conductscience.org/library/genes/7175 | NCBI Gene |
Data2
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7565764
GET https://conductscience.org/api/papers/v1/7565764/references?page=2